To compare two drugs when used with a local anesthetic for upper limb surgeries
Phase 3
- Conditions
- Health Condition 1: M849- Disorder of continuity of bone, unspecified
- Registration Number
- CTRI/2021/01/030500
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA-PS I and II patients posted for upper limb orthopedic surgeries under Supraclavicular brachial plexus block.
Exclusion Criteria
Patient refusal,
Morbidly obese patients (body mass index >35 kg/m2),
Pregnant or lactating women,
Allergy or addiction to study drugs,
Patients receiving chronic analgesic therapy,
Coagulopathies, and
Pre-existing peripheral neuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the onset and duration of sensory and motor blockade. <br/ ><br> <br/ ><br>Timepoint: 1.5 years
- Secondary Outcome Measures
Name Time Method To study duration of postoperative analgesia, requirements of rescue analgesia, and drug-related adverse effects in Supraclavicular Brachial plexus block.Timepoint: 1.5 years